Keywords: MediciNova, Zheijiang, Joint venture, MN-221, China, Asthma

MediciNova sets up JV with Chinese firm Zhejiang Medicine

Article | 08 March 2011

Print This

Japan-based bio-pharmaceutical firm MediciNova (TK: 4875, which is publicly traded in the USA (Nasdaq: MNOV), has signed a letter of intent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in